Nov 10, 2022

First transfusions of lab-grown blood

Posted by in categories: biotech/medical, health

Recently, two patients in the United Kingdom received two small doses of lab-grown blood samples as part of the RESTORE trial.

Image Credit: Sashkin / Shutterstock.com

About the RESTORE trial

The RESTORE trial is a single-center, randomized, controlled, phase I cross-over trial that is a joint effort between the National Health Service (NHS) Blood and Transplant (NHSBT) and the University of Bristol. The aim of this trial is to determine whether blood cells manufactured from donor stem cells perform better than red blood cells (RBCs) obtained from the same donor in recipients.

Comments are closed.